Reducing vancomycin use utilizing a computer guideline: results of a randomized controlled trial
- PMID: 9824802
- PMCID: PMC61335
- DOI: 10.1136/jamia.1998.0050554
Reducing vancomycin use utilizing a computer guideline: results of a randomized controlled trial
Abstract
Background: Vancomycin-resistant enterococci represent an increasingly important cause of nosocomial infections. Minimizing vancomycin use represents a key strategy in preventing the spread of these infections.
Objective: To determine whether a structured ordering intervention using computerized physician order entry that requires use of a guideline could reduce intravenous vancomycin use.
Design: Randomized controlled trial assessing frequency and duration of vancomycin therapy by physicians.
Participants and setting: Three hundred ninety-six physicians and 1,798 patients in a tertiary-care teaching hospital.
Intervention: Computer screen displaying, at the time of physician order entry, an adaptation of the Centers for Disease Control and Prevention guidelines for appropriate vancomycin use.
Main outcome measures: The frequency of initiation and renewal of vancomycin therapy as well the duration of therapy prescribed on a per prescriber basis.
Results: Compared with the control group, intervention physicians wrote 32 percent fewer orders (11.3 versus 16.7 orders per physician; P = 0.04) and had 28 percent fewer patients for whom they either initiated or renewed an order for vancomycin (7.4 versus 10.3 orders per physician; P = 0.02). In addition, the duration of vancomycin therapy attributable to physicians in the intervention group was 36 percent lower than the duration of therapy prescribed by control physicians (26.5 versus 41.2 days; P = 0.05). Analysis of pharmacy data confirmed a decrease in the overall hospital use of intravenous vancomycin during the study period.
Conclusion: Implementation of a computerized guideline using physician order entry decreased vancomycin use. Computerized guidelines represent a promising tool for changing prescribing practices.
Figures




Comment in
-
Clinical information systems--what is the bottom line?J Am Med Inform Assoc. 1998 Nov-Dec;5(6):585-6. doi: 10.1136/jamia.1998.0050585. J Am Med Inform Assoc. 1998. PMID: 9824806 Free PMC article. No abstract available.
References
-
- Uttlely AC, Collins CH, Naidoo J, George RC. Vancomycin resistant enterococci. Lancet. 1988;1(8575-6): 57-8. - PubMed
-
- Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med. 1988;319(3): 157-61. - PubMed
-
- Frieden TR, Munsiff SS, Low DE, et al. Emergence of vancomycin-resistant enterococci in New York City. Lancet. 1993;342(8863): 76-9. - PubMed
-
- Morris JG, Shay DK, Hebden JN, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin: establishment of endemicity in a university medical center. Ann Intern Med. 1995;123(4): 250-9. - PubMed
-
- Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin: United States, 1989-1993. MMWR Morb Mortal Wkly Rep. 1993;42(30): 597-99. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources